Piermont Capital Management Inc. - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 135 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.08 and the average weighting 0.9%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$177,000
-63.8%
14,400
-51.5%
0.06%
-57.9%
Q2 2017$489,000
-2.2%
29,710
-14.8%
0.14%
+17.6%
Q1 2017$500,000
+3.7%
34,8700.0%0.12%
+8.2%
Q4 2016$482,000
-24.9%
34,870
-1.9%
0.11%
-27.6%
Q3 2016$642,00035,5400.15%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$78,084,000100.00%
Artal Group S.A. 57,517,977$1,039,349,00020.58%
NEA Management Company, LLC 2,382,286$43,048,0001.93%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$645,0001.72%
KINGDON CAPITAL MANAGEMENT, L.L.C. 809,666$14,631,0000.67%
MOODY ALDRICH PARTNERS LLC 42,180$762,0000.53%
Cupps Capital Management, LLC 62,549$1,130,0000.49%
BRIDGER MANAGEMENT, LLC 336,966$6,089,0000.41%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 258,353$4,668,0000.34%
Round Table Services, LLC 21,611$391,0000.23%
View complete list of LEXICON PHARMACEUTICALS INC shareholders